Yard Force Robotic Mowers Have Obtained "Green Product" Mark by TÜV
31.1.2023 14:20:00 EET | Business Wire | Press release
Yard Force, a leading manufacturer of innovative outdoor power equipment, has announced the launch of its MB400 and MB800 robotic mowers on the German market. These models come equipped with Bluetooth and app control, providing users with convenient and easy access to their mowers from their smartphones or tablets.
In addition to their advanced technology features, both the Yard Force MB400 and MB800 come with a unique feature that allows for decking to be cleaned using water. This innovative feature not only makes cleaning the decking easier, but also helps to prevent the build-up of algae and other contaminants that can affect the appearance and longevity of the decking.
The Yard Force MB400 and MB800 are also equipped with a free garage, providing users with a convenient and secure storage solution for their mowers. This is particularly useful for those who wish the robotic mower could find shelter during rain or snow and use the robotic mower for a longer life.
Yard Force launches the two new models on the 10th anniversary of its robotic mowers, setting the standard once again:
In addition to their impressive features, both the Yard Force MB400 and MB800 have been awarded the "Green Product" certification by TÜV, a leading certification organizaition for environmental, social, and governance (ESG) standards. This certification recognizes the mowers' eco-friendly design and technology, making them a smart and sustainable choice for homeowners looking to reduce their carbon footprint.
In 2013, the company started selling its robotic mowers in Germany and has since equipped tens of thousands of German gardens with the innovative and practical robotic mowers.
The new Yard Force MB400 and MB800 are designed to provide users with a convenient and efficient solution for maintaining their lawns. With maximum 400m2 and 800 m2 working area respectively, these mowers are perfect for small to medium sized lawns, and can easily navigate around obstacles such as trees and garden furniture.
The Bluetooth and app control features of the Yard Force MB400 and MB800 allow users to easily set up and customize their mowing schedule, as well as monitor the mower's performance and receive notifications on their smartphone or tablet. This level of control and convenience makes the MB400 and MB800 a popular choice for busy homeowners who want to maintain their lawns without the hassle of traditional mowing methods.
The decking cleaning feature of the Yard Force MB400 and MB800 is another standout feature that sets these mowers apart from their competitors. By using water to clean the decking, users can easily remove dirt and debris, ensuring that their decking stays looking clean and fresh all year round. This feature also helps to prevent the build-up of algae and other contaminants, which can damage the decking and reduce its lifespan.
Overall, the Yard Force MB400 and MB800 are a highly innovative and convenient solution for maintaining a healthy and well-groomed lawn. With their advanced technology, eco-friendly design, and unique decking cleaning feature, these mowers are sure to be a hit with German homeowners looking for a more efficient and sustainable way to care for their lawns.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230131005560/en/
Contact information
Email: linyinlu@sumec.com.cn
Phone number: +86-13770517766
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
